Published January 26, 2023
| Version v1
ANALYSIS OF DATA ON COVID-19 IN ALBANIA FOR THE FIRST QUARTER OF 2020 AND 2021
Notes
References:
1. .github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data
2. github.com/datasets/covid-19/tree/main/data
3. Misho,E.,2020.COVID-19ANDIMPACTONENVIRONMENTALANDINTERNATIONALLAEIN ALBANIA. 7th International Scientific Conference "Social Changes in the Global Eorld", [online] (341:502),pp.127-130.Availableat:[Accessed11March2021].
4. Kuci, S., Ibrahimi, A., Bejko, E., Llazo, S., Goga, M., Likaj, E., Kacani, A., Collaku, A. and Dhimitri, D., 2021.Treatment of COVID-19 Complications at Home Conditions. Albanian Journal of Trauma and Emergency Surgery,5(1),pp.823-828.
5. ArcGIS. Johns Hopkins University. Retrieved 19 January 2023.
6. ^ Page J, Hinshaw D, McKay B (26 February 2021). "In Hunt for Covid-19 Origin, Patient Zero Points to Second Wuhan Market – The man with the first confirmed infection of the new coronavirus told the WHO team that his parents had shopped there". The Wall Street Journal. Retrieved 27 February 2021.
7. ^ Islam MA (April 2021). "Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients". PLOS ONE. 16 (4): e0249788. Bibcode:2021PLoSO..1649788I.
8. Islam MA (April 2021). "Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients". PLOS ONE. 16 (4): e0249788. Bibcode:2021PLoSO..1649788I. doi:10.1371/journal.pone.0249788. PMC 8023501. PMID 33822812.
9. ^ Islam MA (November 2020). "Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients". Frontiers in Neurology. 11: 562634. doi:10.3389/fneur.2020.562634. PMC 7728918. PMID 33329305.
10. ^ Saniasiaya J, Islam MA (April 2021). "Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients". The Laryngoscope. 131 (4): 865–878. doi:10.1002/lary.29286. ISSN 0023-852X. PMC 7753439. PMID 33219539.
11. ^ Saniasiaya J, Islam MA (November 2020). "Prevalence and Characteristics of Taste Disorders in Cases of COVID-19: A Meta-analysis of 29,349 Patients". Otolaryngology–Head and Neck Surgery. 165 (1): 33–42. doi:10.1177/0194599820981018. PMID 33320033. S2CID 229174644.
12. ^ Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R (August 2020). "Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis". Mayo Clin. Proc. 95 (8): 1621–1631. doi:10.1016/j.mayocp.2020.05.030. PMC 7275152. PMID 32753137.
13. ^ Oran DP, Topol EJ (January 2021). "The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review". Annals of Internal Medicine. 174 (5): M20-6976. doi:10.7326/M20-6976. PMC 7839426. PMID 33481642.
14. ^ "Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)". U.S. Centers for Disease Control and Prevention (CDC). 6 April 2020. Archived from the original on 2 March 2020. Retrieved 19 April 2020.
15. ^ Jump up to:a b CDC (11 February 2020). "Post-COVID Conditions". U.S. Centers for Disease Control and Prevention (CDC). Retrieved 12 July 2021.
16. ^ CDC (11 February 2020). "Coronavirus Disease 2019 (COVID-19)". U.S. Centers for Disease Control and Prevention (CDC). Retrieved 6 December 2020.
17. ^ "Clinical Questions about COVID-19: Questions and Answers". U.S. Centers for Disease Control and Prevention (CDC). 17 November 2021. Retrieved 25 January 2022.
18. ^ Jump up to:a b c "Overview of Testing for SARS-CoV-2, the virus that causes COVID-19". U.S. Centers for Disease Control and Prevention (CDC). 11 February 2020. Retrieved 31 July 2022.
19. ^ Jump up to:a b c "Nucleic Acid Amplification Tests (NAATs)". U.S. Centers for Disease Control and Prevention (CDC). 11 February 2020. Retrieved 31 July 2022.